MASH1

Clear
SKU: 3131 Categories: , ,

Achaete-scute complex homolog-1 (ASCL1), known as mASH1 in rodents and hASH1 in humans, is a basic helix-loop-helix transcription factor that is critical for neuroendocrine cell differentiation (1,2). Neuroendocrine carcinomas can arise in different sites such as lung, the gastrointestinal tract, prostate and skin (2). High grade, poorly differentiated neuroendocrine carcinomas are classified as neuroendocrine carcinomas (NECs) and are distinguished from low grade neuroendocrine tumors (NETs) (2,3). Classic neuroendocrine markers such as chromogranin and CD56 cannot distinguish NECs from NETs (2). Studies have shown that the mouse monoclonal antibody MASH1 [24B72D11.1] stains hASH1 in human tissues and can distinguish NECs from NETs in various sites (3-5). MASH1 has also been shown to distinguish
large cell neuroendocrine carcinomas (LCNECs) and small cell lung carcinomas (SCLCs) from other phenotypes of lung cancer (3-5). MASH1 has also been used to differentiate SCLC from Merkel cell carcinoma (6). While not a tissue-specific marker, MASH1 may assist in distinguishing neuroendocrine carcinomas from neuroendocrine tumors in poorly differentiated cases (2).

Intended Use

IVD

Format

Concentrate, Predilute

Volume

0.1 ml, 6.0 ml

Source

Mouse Monoclonal

Clone

24B72D11.1

Isotype

IgG1

Antigen

achaete-scute complex homolog-1

Localization

Nuclear

Positive Control

Small cell lung cancer

Species Reactivity

Human, Others Not Tested

1. Ball DW, et al. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci U S A. 1993 Jun 15; 90(12):5648-52.
2. La Rosa S, et al. Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases. Hum Pathol. 2013 Jul; 44(7):1391-9.
3. Schnabel PA, Junker K. Neuroendocrine tumors of the lungs: From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Pathologe. 2014 Nov; 35(6):557-64.
4. Hiroshima K, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol. 2006 Oct; 19(10):1358-68.
5. Jiang SX, et al. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod Pathol. 2004 Feb; 17(2):222-9.
6. Ralston J, Chiriboga L, Nonaka D. MASH1: a useful marker in differentiating pulmonary small cell carcinoma from Merkel cell carcinoma. Mod Pathol. 2008 Nov; 21(11):1357-62.
7. Center for Disease Control Manual. Guide: Safety Management, NO. CDC-22, Atlanta, GA. April 30, 1976 “Decontamination of Laboratory Sink Drains to Remove Azide Salts.”
8. Clinical and Laboratory Standards Institute (CLSI). Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline-Fourth Edition CLSI document M29-A4 Wayne, PA 2014.